Zafgen, Inc (ZFGN) Covered Calls

Zafgen, Inc covered calls Zafgen Inc is a biopharmaceutical company dedicated to improving the health and well-being of patients affected by obesity. Beloranib is the Company's product candidate.

You can sell covered calls on Zafgen, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ZFGN (prices last updated Tue 4:16 PM ET):

Zafgen, Inc (ZFGN) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
5.30 +0.17 5.10 5.56 196K - 0.0B
Covered Calls For Zafgen, Inc (ZFGN)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 5 0.00 5.56 -10.1% -335.1%
Jan 18 5 0.00 5.56 -10.1% -94.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Zafgen, Inc. is a biopharmaceutical company, which is engaged in the developing of anti-obesity therapeutics that restores normal fat metabolism and regulatory pathways. The company's product: Beloranib, which is under phase 2 clinical development as a treatment for obesity and hyperphagia in Prader-Willi Syndrome, or PW craniopharyngioma-associated obesity. Zafgen was founded on November 22, 2005 and is headquartered in Boston, MA.